CMED Initiates Dialogue on Review of Drug Pricing Rules
QR Group analyzes the impacts of the proposal on the pharmaceutical sector and how companies can prepare for the new regulatory scenario The Drug Market Regulation Chamber (CMED), linked to ANVISA, announced in July 2025 the start of a structured dialogue with the regulated sector to discuss the revision of drug pricing rules in Brazil. […]
RDC 954: Simplified Registration of Medications and Its Impacts
ANVISA Event Details Changes in RDC 954/2024 On March 13, ANVISA held an exclusive event on RDC 954/2024, which brings important updates to the simplified registration of medicines. The high demand for face-to-face participation led to the opening of online transmission, allowing a greater number of professionals to follow the changes in real time. QR […]
